| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | Avilamycin Basic information |
| Product Name: | Avilamycin | | Synonyms: | (59S)-59-Deoxo-23-deoxy-59-hydroxyflambamycin;Avilamycin C;β-D-Mannopyranoside, O-(1R)-6-deoxy-4-C-[(1S)-1-hydroxyethyl]-2,3-O-methylene-D-galactopyranosylidene-(1→3-4)-2-O-(2-methyl-1-oxopropyl)-α-L-lyxopyranosyl O-2,6-dideoxy-4-O-(3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoyl)-β-D-arabino-hexopyranosyl-(1→4)-O-2,6-dideoxy-D-arabino-hexopyranosylidene-(... | | CAS: | 69787-80-0 | | MF: | C61H90Cl2O32 | | MW: | 1406.26 | | EINECS: | | | Product Categories: | | | Mol File: | 69787-80-0.mol |  |
| | Avilamycin Chemical Properties |
| density | 1.50±0.1 g/cm3(Predicted) | | pka | 4.94±0.35(Predicted) |
| | Avilamycin Usage And Synthesis |
| Uses | Avilamycin C is an avilamycin-type antibiotic. Avilamycin C has antibacterial activity and can inhibit Gram-positive bacteria[1][2]. | | References | [1] Zhang D, et al. An NADH/NAD+-favored aldo-keto reductase facilitates avilamycin A biosynthesis by primarily catalyzing oxidation of avilamycin C. Appl Environ Microbiol. 2024 Apr 17;90(4):e0015024. DOI:10.1128/aem.00150-24
[2] Weitnauer G, et al. Biosynthesis of the orthosomycin antibiotic avilamycin A: deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and production of new antibiotics. Chem Biol. 2001 Jun;8(6):569-81. DOI:10.1016/s1074-5521(01)00040-0 |
| | Avilamycin Preparation Products And Raw materials |
|